Dr. Sule Canberk, MD, PhD, MIAC

Dr. Canberk is an endocrine pathologist and cytopathologist who recently completed her PhD in Molecular Pathology and Genetics at the University of Porto, Portugal. During her medical education, she interned at Ludwig Maximilian University in Munich, Germany, and later completed a residency in anatomic pathology followed by a fellowship in cytopathology. She served as an assistant professor in the Department of Pathology at Acibadem University for four years and continues to provide second opinions via telepathology for thyroid samples at ACU.

Dr. Canberk has authored 68 peer-reviewed publications in leading pathology and cytopathology journals and contributed five book chapters. She has delivered numerous lectures, workshops, and short courses at international conferences, including the International Cytology Congress (ICC), European Cytology Congress (ECC), Asia and Oceania Thyroid Association (AOTA), and Porto Cancer meetings. She remains committed to advancing the cytopathology of the thyroid and lung.

She completed observerships in cytopathology at the University of Pennsylvania in 2012 and 2013 and has pursued extensive training in bioinformatics, including courses in transcriptomics and proteomics at the European Bioinformatics Institute (EBI-EMBL) during her PhD. Dr. Canberk is an active member of the thyroid research group “Cancer Signalling and Metabolism” in Porto, focusing on the genetic basis and phenotypic variation of oncocytic thyroid tumors. Her PhD project, titled "Diabetes Mellitus and Oncocytic Tumors of the Thyroid: The Mitochondrial Connection," was funded by the National Foundation of Science and Technology (SFRH/BD/147650/2019). She has been twice awarded by the Portuguese Society of Endocrinology, Diabetes, and Metabolism (SPEDM) for her research on the interactions between the BRAFV600E mutation and the mTOR pathway in papillary thyroid carcinoma (2018) and for her work on diabetes and oncocytic thyroid tumors (2019).